NA Proactive news snapshot: Dyadic, 1933 Industries, PyroGenesis Canada, Q BioMed UPDATE …

Dyadic International Inc (NASDAQ:DYAI) announced Monday that it has entered into a nonexclusive research collaboration with WuXi Biologics, a leading global open-access biologics technology company in China. Under the terms of the research license agreement, Dyadic will grant WuXi Biologics restricted access to its proprietary and patented C1 gene expression platform. In addition, Dyadic said it will allow WuXi Biologics, which is also a Contract Development and Manufacturing Organization (CDMO), to evaluate the C1 technology in a GMP facility and to perform certain experiments to the C1 cell lines for any other internal noncommercial purpose. WuXi Biologics, one of the world’s top 10 CDMOs that provides development and manufacturing services to pharmaceutical and biotechnology companies, will invest its own resources to evaluate the C1 platform for its customers worldwide, Dyadic said. 1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF), a vertically-integrated cannabis consumer goods company, said that it has begun its second cannabis harvest from its cutivation facility in Las Vegas, Nevada. In a statement, the Canadian company pointed out this marked the beginning of "continuous harvests" in Nevada as it swung into full production. "This is an important milestone for our company ... We have spent several months optimizing the new Las Vegas facility, enhancing our genetics programme to develop varieties of strains and cultivars to meet the demands of our consumers and we are pleased with our progress to date,” said 1933 Industries CEO Chris Rebentisch. 1933 Industries will be using the current harvest to produce its popular AMA branded concentrates and for its licensed brands Blonde and Denver Dab Co. PyroGenesis Canada Inc (CVE:PYR) (OTCQB:PYRNF) partner HPQ Silicon Resources Inc (CVE:HPQ) said Monday that interest for its silicon metal products remains strong in the face of the coronavirus outbreak. The company is seeing “meaningful interest” from the battery industry in its PUREVAP RRQ Silicon Metal, which is used as a feedstock to manufacture spherical silicon metal nano powders and nanowires for lithium-ion batteries. “The COVID-19 outbreak, possible recession and low oil prices don’t change the long-term cyclical movement of the Renewable Energy Revolution,” HPQ’s CEO Bernard Tourillon said in a statement. Q BioMed Inc (OTCQB:QBIO) has named seasoned pharmaceutical and biotechnology professional Kristin Keller its new Chief Commercial Officer, handing her the reins to the global commercialization effort of its metastatic bone pain treatment, Strontium89. Keller has worked for more than two decades as a marketer and strategist for global pharmaceutical, biotechnology and medical device companies, and she brings extensive experience in the specialty and orphan drug space. Nemaura Medical Inc (NASDAQ:NMRD), a UK-based company focused on diabetes, announced Monday that it is planning to launch a digital healthcare subscription service in the US under the brand name proBEAT. The company said that proBEAT is expected to be available without the need for a prescription and appeal to a broad range of adults encompassing pre-diabetic and Type 2 diabetics - 88 million and 26 million people, respectively - as well as those seeking to lose weight and have a healthier lifestyle. CytoDyn Inc (OTCMKTS:CYDY) announced Monday that three more critically ill coronavirus (COVID-19) patients have been treated with the company’s drug leronlimab, bringing the number of patients treated with it to ten. The use of leronlimab, which has other therapeutic indications as a treatment for HIV and certain breast cancers, is being administered under an emergency Investigational New Drug Application (IND) recently granted by the US Food and Drug Administration (FDA). The new patients, like the seven before them, are being treated at a leading New York City hospital, the company said. CB2 Insights Inc (CSE:CBII) (OTMKTS:CBIIF), the medical cannabis research, data and education group, has extended the reach of its business with the launch of a new interactive dashboard for use by stakeholders. The dashboard, accessed via the firm's website at https://cb2insights.ca/data, is free and offers key patient insights derived from the firm's clinical operations. It was created to answer hundreds of questions from global industry stakeholders, including government agencies and major research groups. It also allows users to submit additional data requests directly to CB2's research and data team. Orgenesis Inc's (NASDAQ:ORGS) CEO Vered Caplan told shareholders Monday that its research and development labs are still operating during the coronavirus (COVID-19) pandemic. “We are leveraging all our knowledge and expertise in the field of cell and gene therapy, including anti-viral technologies relevant to COVID-19. We look forward to providing further updates on this front in the very near future,” Caplan said in a statement. Humanigen Inc (OTCMKTS:HGEN) shares rose on Monday as it announced that it will partner with contract research organization, CTI Clinical Trial and Consulting Services (CTI) on a Phase III clinical trial for lenzilumab to help coronavirus (COVID-19) patients, if a study is approved. The biotech's monoclonal antibody lenzilumab is aimed at treating cytokine storm, which can lead to acute respiratory distress syndrome (ARDS), which is associated with the current deadly form of COVID-19. Loop Insights Inc (CVE:MTRX) said Monday it is launching a new initiative to help retailers and hospitality storefronts land on their feet after the coronavirus pandemic eases. The new initiative, called “Sharing is Caring,” is designed for small business owners facing uncertainty after most governments mandated non-essential retail and food establishments to close their doors in an effort to halt the spread of the virus. Vancouver-based Loop is offering a free three-part webinar series to discuss the state of the retail industry and share ways that business owners can prepare for the eventual reopening of physical stores. GR Silver Mining Ltd (CVE: GRSL (OTCQB:GLYXF) has completed its acquisition of the past-producing Plomosas silver project in Mexico, giving it a commanding position and potential to expand in the exciting Rosario mining district. The vendor is major silver producer First Majestic Silver Corp (NYSE:AG) (TSE:FR), which becomes the group's largest strategic shareholder with a 19.9% holding. Japan Gold Corp (CVE:JG) (OTCQB:JGLDF) announced on Monday that it is shuffling its executive team. The Vancouver-based mineral explorer announced that president Michael Andrews and executive vice president John Carlile have resigned to pursue other opportunities. Meanwhile, Rafaela Vartuli is joining the firm as its new corporate communications manager, the company said. Parallax Health Sciences Inc (OTCMKTS:PRLX) said Monday that its subsidiary, Parallax Diagnostics Inc, has executed a joint venture supply chain agreement with the United States Marine Corps veteran-owned medical device company SAGICO USA for coronavirus (COVID-19) and personal protection equipment (PPE), from FDA-registered manufacturers. SAGICO USA has a long track-record for getting US Food and Drug Administration (FDA) clearances, and other regulatory approvals for the distribution of medical products to government hospitals globally. The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCQX:TGODF) announced Monday that its Ancaster processing facility is ready to begin production after receiving approval of a license amendment from Health Canada. The facility expansion at Ancaster includes dedicated areas for the packaging of flower, oils, pre-rolls, as well as Cannabis 2.0 edible and ingestible products. Dunnedin Ventures Inc (CVE:DVI) (OTCMKTS:OTCFF) has confirmed that its name change to Kodiak Copper Corp will officially take place on Wednesday, April 1. In a statement, the copper-focused resource group said it has now received all necessary approvals and shares under the new name will start trading on Toronto's Venture Exchange under the ticker symbol 'KDK' on that date. The new shares have been consolidated on the basis of one new post-consolidation share for every five pre-consolidation shares. eWellness Healthcare Corporation (OTCQB:EWLL) announced Monday that a number of major health insurers including UnitedHealthcare, CIGNA, Anthem Blue Cross and Blue Shield of California have moved to make digital physical therapy fully reimbursable.  As many physical therapists (PTs) are currently unable to meet with patients in person due to the coronavirus (COVID-19), telemedicine options like eWellness’ PHIZIO program allow them to provide assessment and treatment in real-time using a smartphone or laptop. Fura Gems Inc (CVE:FURA) (OTCMKTS:FUGMF) is extending the drop-dead date for its acquisition of ruby assets in Mozambique, the group said on Monday. The Toronto-based company said it gave New Energy Minerals Ltd written notice on March 26 to extend the date from March 31, 2020, to June 30, 2020. The acquisition gives Fura interests in three ruby licenses in Mozambique. Great Bear Resources Ltd (CVE:GBR) (OTCMKTS:GTBDF), the Red lake gold explorer, has begun mailing shareholders details of a special meeting to vote for the, previously announced, planned spin-out of subsidiary Great Bear Royalties Corp into a separate company. The meeting is to be held on April 23 at 1pm (PST) at the offices of Blake, Cassels & Graydon LLP, Burrard Street, Vancouver. Immunoprecise Antibodies Ltd (CVE:IPA) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 1,244,792 shares at a deemed price of 60 cents to four arm's-length creditors to settle outstanding debt for $746,875. NexTech AR Solutions Corp (OTCMKTS:NEXCF), based in Toronto Ontario, announced that Evan Gappelberg, CEO, will present live at VirtualInvestorConferences.com on Thursday, April 2 at 10:30 am EST via the link: https://tinyurl.com/April2TechVIC. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. Investors can learn more about the event at www.virtualinvestorconferences.com Life Sciences Investor Forum announced that the presentations from its inaugural conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. The virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth." Milestone Scientific Inc (NYSEAMERICAN:MLSS), the biomedical technology company behind DPS Dynamic Pressure Sensing technology, will host a conference call to discuss its 2019 full year results and other business developments at 8:30 am ET on Tuesday, March 31. The call will be available at milestonescientific.com, or by dialing toll free 877-407-0778 in the US or +1 201-689-8565 internationally. A webcast and telephone replay of the call will be available roughly one hour after its conclusion through April 14.